Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
Generic Midamor
Identification of Selective Inhibitors of the Potassium Channel Kv1.1-1.2((3)) by High-Throughput Virtual Screening and Automated Patch Clamp.
Vitamin D receptor binding, chromatin states and association with multiple sclerosis.
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
Health Canada Approves PLEGRIDY™ (peginterferon beta-1a) for Adults with Relapsing Remitting Multiple Sclerosis
Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.
Stress signaling etches heritable marks on chromatin.
MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8(+) T cells.
Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-beta-1b: a case report.
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS.
Artielle Immunotherapeutics Announces Positive Results of Phase ! Multiple Sclerosis Trial
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
The International Symposium on the Multiple Sclerosis Brain
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.
Value and Efficacy of Transcranial Direct Current Stimulation in the Cognitive Rehabilitation: A Critical Review Since 2000.
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.
Development of the Brief Inventory of Perceived Stress.
Time limited immunomodulatory functions of transplanted neural precursor cells.
Double blind placebo-controlled Phase I/II clinical trial of idebenone in patients with primary progressive multiple sclerosis (IPPoMS)
Clinical and MRI characterization of MS patients with a pure and severe cognitive onset.
Pilates based core stability training in ambulant individuals with multiple sclerosis: Protocol for a multi-centre randomised controlled trial.
An Open Label Extension of the LAQ/5062 and LAQ/5063 Studies to Assess the Long Term Safety and Tolerability of Laquinimod 0.6mg in RRMS Patients
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

Pages